Beamtree is delighted to announce agreement of a five-year contract with Ampath, a leading provider of pathology services in South Africa for the provision of its RippleDown decision support product.
RippleDown is Beamtree’s proprietary software which automates clinical and administrative process in healthcare, in pathology.
The partnership with Ampath follows a successful proof-of-concept pilot that examined how RippleDown can help Ampath laboratories drive the best pathology services, better healthcare, safety and value for money. It features the following Beamtree products:
- RippleDown Expert, which automatically applies clinical expertise to generate patient-centric reports, replicating decision-making processes at scale that would normally be completed by human experts
- RippleDown Auditor, which applies billing and revenue rules to ensure healthcare claims are accurate – improving value for money, safety and compliance
Beamtree CEO Tim Kelsey said: “We look forward to working with Ampath and demonstrating the value of RippleDown to enhance quality, safety, accuracy and insight in pathology. We share Ampath’s passion for improving healthcare internationally. RippleDown is the world’s leading platform for automation of human expertise and is now operating in more than 20 countries. This key partnership underscores the global opportunity for our world-class technology.”
Share this article
